Top-Analysts PicksInvest alongside the top 15% of Wall Street analysts.

Try Top-Picks
Nuvation Bio Inc. Financials Banner

Nuvation Bio Inc. Financials

NUVB Stock Analysis

Page title

Section title

NUVB Income Statement Key Metrics

  • Revenue(TTM)1.70 M
  • Gross Profit(TTM)-60,000
  • EBITDA(TTM)-112.67 M
  • Net Income(TTM)-510.72 M
  • EPS Diluted(TTM)-2.1102000000000003

Decode NUVB's Latest Earnings Call with Ease

Tap 'Generate' for a crystal-clear,
AI-crafted summary and stay ahead in the investment game!

NUVB earnings and revenue history

NUVB Return on Equity

See how efficiently NUVB generates profit for it's shareholders.

-12.53%

10
0
100
  1. Poor

  2. Average

  3. Strong

Return on Equity vs Peers

Return on Equity ratio of NUVB (-0.125) is higher than the average of its peers (-0.489).

Return on Equity Growth

NUVB's Return on Equity has grown significantly over the past 10 years, increasing by over 32.58%.

NUVB Revenue Growth

See how NUVB has grown it's revenue over the past 10 years.


Revenue Growth

NUVB's revenue has shown poor growth over the past 10 years, increasing by only 0%.

NUVB FY, 2023 Revenue Breakdown

See how NUVB converts it's revenue into profit.

NUVB Balance Sheet Health

NUVB Balance Sheet Breakdown 2023

Assets

  1. Long Term Assets

  2. Cash & Equivalents

  3. Inventory

  4. Receivables

  5. Property Plant Equipments

  6. Others

Liabilities

  1. Short Term Debt

  2. Long Term Debt

  3. Account Payables

  4. Others

NUVB financial position analysis

Short Term Liabilities

NUVB's short term assets($616M) can safely cover it's short term liabilities($14M).

Long Term Liabilities

NUVB's short term assets($616M) can safely cover it's long term liabilities($2M).

NUVB Debt to Equity